This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A REPORT OF FOURTEEN CASES

FRANCIS D. MURPHY, M.D.; JOSEPH F. KUZMA, M.D.; THEODORE Z. POLLEY, M.D.; JOHN GRILL, M.D.

Arch Intern Med. 1944;73(6):433-443.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

It has become widely recognized that the kidney may be damaged in the course of therapy with sulfonamide compounds. Such renal complications may be classified roughly as follows: 1. Mechanical complications produced by masses of crystals of the sulfonamide compounds in the kidneys, pelves and ureters. These lead to obstructive lesions. This group may be further subdivided into (a) the extranephric, in which the concretions causing obstruction are within the pelves of the kidney or in the ureters, and (b) the intranephric, in which the concretions are in the kidney substance itself. 2. Toxic intrarenal lesions without mechanical obstruction. These lesions occur within the kidney and are not associated with mechanical obstruction but may be attributed to the toxic effect of the sulfonamide compound on the parenchymal tissue. This class may be divided into three groups, which represent different phases of the same reaction and are not distinct divisions: (a) . . . [Full Text PDF of this Article]

Author Affiliations
MILWAUKEE

From the Department of Medicine, Marquette University School of Medicine, and the Medical Clinics and Department of Pathology, Milwaukee County General Hospital.

Footnotes
Presented before the Sixteenth Annual Meeting of the Central Society for Clinical Research, Chicago, Nov. 5, 1943.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?